Form 4: CervoMed Director Joshua Boger Acquires Stock Options Following Board Election
SEC Form 4 Filing
Joshua Boger, a director of CervoMed Inc., was granted options to purchase 5,750 shares of common stock on June 14, 2024, following his election to the board.
Summary
- On June 14, 2024, Joshua Boger, a director of CervoMed Inc., received an option to purchase 5,750 shares of the company's common stock.
- The grant was made in connection with Boger's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders.
- The option was granted under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy.
- The exercise price of the stock option is $19.01.
- The shares underlying the option will vest monthly over a one-year period, starting June 30, 2024, contingent upon Boger's continued service.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options to a director is a routine event and generally viewed as a positive sign of aligning interests.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
This is a standard practice for compensating non-employee directors, aligning their interests with the long-term success of the company. Equity grants are a common component of director compensation packages in the biotechnology industry.
Comparison to Industry Standards
- Director compensation packages, including stock options, are common in the biotech industry.
- Companies like Amgen, Biogen, and Gilead Sciences also use equity-based compensation to align director interests with shareholder value.
- The vesting schedule of one year is fairly standard for director equity grants.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Joshua Boger | 06/14/2024 | Election to the board of directors |
Stakeholder Impact
- Shareholders: Aligns director's interests with shareholder value through equity ownership.
- Employees: May have a slight positive impact as it reinforces the company's commitment to attracting and retaining talent.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of transaction: Joshua Boger granted stock options and elected to the board of directors. |
| 06/30/2024 | First vesting date for the stock options. |
| 06/14/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.